World
GLP-1 drugs carry potential risk of rare eye condition NAION: FDA The FDA on Monday warned that GLP-1 drugs carry a potential risk for a rare but serious eye condition that's sometimes referred to as an "eye stroke.".
The FDA on Monday warned that GLP-1 drugs carry a potential risk for a rare but serious eye condition that's sometimes referred to as an "eye stroke.".
Dr. Kai NakamuraChief Science CorrespondentPublished Nov 9, 2026 at 11:28 AM EST · 1 min read
GLP-1 drugs carry potential risk of rare eye condition NAION: FDA The FDA on Monday warned that GLP-1 drugs carry a potential risk for a rare but serious eye condition that's sometimes referred to as an "eye stroke.". The FDA on Monday warned that GLP-1 drugs carry a potential risk for a rare but serious eye condition that's sometimes referred to as an "eye stroke.".
Continue reading
Latest →Corrections, sourcing and article labels are part of the publication record. See our editorial standards.